Authors: MUSS HB CASE LD ATKINS JN BEARDEN JD COOPER MR CRUZ JM JACKSON DV OROURKE MA PAVY MD POWELL BL RICHARDS F SPURR CL EAGLE K WHITE DR

Citation: Hb. Muss et al., TAMOXIFEN VERSUS HIGH-DOSE ORAL MEDROXYPROGESTERONE ACETATE AS INITIAL ENDOCRINE THERAPY FOR PATIENTS WITH METASTATIC BREAST-CANCER - A PIEDMONT-ONCOLOGY-ASSOCIATION STUDY, Journal of clinical oncology, 12(8), 1994, pp. 1630-1638